CLINICAL SCIENCE. J Acquir Immune Defic Syndr Volume 61, Number 1, September 1,
|
|
- Ross Hensley
- 5 years ago
- Views:
Transcription
1 CLINICAL SCIENCE HIV Prevention: Male Circumcision Comparison Between a Nonsurgical Device to a Surgical Technique in Resource-Limited Settings: A Prospective, Randomized, Nonmasked Trial Vincent Mutabazi, MD,* Steven A. Kaplan, MD, Emile Rwamasirabo, MD, Jean Paul Bitega, MD, Muyenzi Leon Ngeruka, MD, Dominique Savio, MD,k Corine Karema, MD,* and Agnes Binagwaho, MD* Background: Randomized controlled trial studies have shown that male circumcision (MC) can reduce the risk of HIV infection by 53% 60%. The Joint United Nations Program on HIV and AIDS announced a 5-year plan to voluntarily circumcise 20 million men by There are more than 38 million males in sub-saharan Africa that could benefit from MC for HIV prevention by Surgical MC is impractical for nation-wide coverage in resource-limited settings. Rwanda intends to launch a voluntary MC program to reach 2 million adult men in 2 years, an unattainable goal with surgical MC. This study was designed to compare a new nonsurgical device with surgical MC to assess nonsurgical MC suitability for scale-up. Methods: Prospective, randomized controlled trial in Rwanda in which the PrePex device was used for nonsurgical MC and the dorsal-slit method for surgical MC (ratio: 2:1). Subjects were healthy adult male volunteers aged years. The primary endpoint, set by World Health Organization, was total MC procedure time. Received for publication March 1, 2012; accepted June 5, From the *Ministry of Health, Republic of Rwanda, Kigali, Rwanda; Department of Urology, Weill Cornell Medical College, Cornell University, New York, NY; Department of Surgery, King Faisal Hospital, Kigali, Rwanda; Department of Surgery, Kanombe Military Hospital, Kigali, Rwanda; kkigali University Teaching Hospital, Kigali, Rwanda; and Harvard University, Cambridge, MA. This study was funded by the Government of Rwanda; PrePex devices were provided by Circ MedTech Limited (Tortola, British Virgin Islands). Preliminary results were presented at AIDS Impact 10th International Conference; September 13, 2011; Santa Fe, New Mexico. The authors V. Mutabazi literature search, figures, study design, data collection, data analysis, data interpretation, writing; S. A. Kaplan study design, data analysis, data interpretation; E. Rwamasirabo data analysis, data interpretation; J. P. Bitega literature search, figures, study design, data collection, data analysis, data interpretation, writing; M. L. Ngeruka literature search, figures, study design, data collection, data analysis, data interpretation, writing; C. Karema study design, data analysis, data interpretation; D. Savio data analysis, data interpretation; A. Binagwaho literature search, figures, study design, data collection, data analysis, data interpretation, writing. The authors have no conflicts of interest to disclose. This study is registered at clinicaltrials.gov (NCT ). Correspondence to: Vincent Mutabazi, MD, Rwanda Biomedical Center/Institute of HIV Disease Prevention and Control, B.P 2717, Kigali, Rwanda ( mutabazivincent@yahoo.com). Copyright 2012 by Lippincott Williams & Wilkins Findings: Of 217 eligible subjects, 144 were randomized to the PrePex/nonsurgical arm and 73 to the surgical arm. All subjects were circumcised in 10 working days. Nonsurgical MC was bloodless, without anesthesia, sutures, or sterile setting and with mean procedure time of 3.1 minutes (skin to skin), was significantly shorter than mean surgical procedure time (15.4 minutes skin to skin) (P, ). There were no device-related adverse events. Healing time of the PrePex arm was longer than the surgical arm. Conclusion: PrePex, the nonsurgical MC, takes significantly less time than surgical, is as safe, does not require injections or sterile settings, is bloodless and seems to be suitable for nurses. Key Words: nonsurgical, male circumcision, HIV, rwanda, surgical circumcision, PrePex (J Acquir Immune Defic Syndr 2012;61:49 55) INTRODUCTION Randomized and controlled studies have shown that male circumcision (MC) can reduce the lifetime risk of HIV infection by 53% 60%, 1 4 and results of the 4-year longitudinal study ( ) carried in Orange Farm, South Africa, indicate a reduction in HIV incidence of 76%. 5 The World Health Organization (WHO) and UNAIDS recommend that MC be considered as an HIV prevention means in addition to other HIV prevention means in countries with predominantly heterosexual epidemics. 6 There are more than 38 million adolescent and adult males in Africa that could benefit from MC for HIV prevention. 7,8 About 15% of all men in the Republic of Rwanda have been circumcised. 9 The government plans to implement a nation-wide circumcision program with the objective of facilitating voluntary circumcision of 2 million adult men in Rwanda within 2 years to achieve a goal of decreasing HIV incidence rate by 25% in the fifth year from scale-up initiation, calculated by a national task force. However, given current resource limitations, such a goal is unattainable using standard surgical methods, the only approved method by the WHO. Today in Rwanda, there are a total of 21 surgeons, assuming each surgeon will be able to provide 20% of his work time for MC and assuming 15 minutes for 1 MC, there J Acquir Immune Defic Syndr Volume 61, Number 1, September 1,
2 Mutabazi et al J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 can be maximum 32,256 MCs done per year in Rwanda by surgical means. Government sought to investigate solutions for nonphysicians in nonsterile settings, thus minimizing the burden on the existing health care system, which is already strained handling life-saving procedures. This prospective, randomized, controlled study was sponsored by Rwanda to measure the performance of the nonsurgical PrePex device compared with a WHO-approved method of surgical MC for rapid scale-up in resource-limited settings. METHODS Trial Design This was a single-center nonmasked randomized controlled trial to compare the performance of nonsurgical MC using the PrePex device versus an approved WHO method of surgical MC in adults, over a period of 9 weeks with an allocation ratio of 2:1, allocation ratio is based on WHO recommendation. 10 The study was carried out in the Nyamata District Hospital, Rwanda, a rural area 35 kilometers from Kigali City. Study period per subject was 9 weeks. This study was approved by the Rwanda National Ethics Committee on January 13, 2011, approval number N0 001/RNEC/2011. Intervention All surgical MCs were conducted by surgeons experienced in circumcision. All nonsurgical MC procedures were performed by surgeons who participated in prior safety and efficacy studies using PrePex in Rwanda. 11 Surgeons of each arm did not perform MC procedures in the other arm, and all surgeons had the same level of MC experience. PrePex Nonsurgical MC Arm Procedure was bloodless and performed without anesthesia or sutures and in a standard inspection room. Subjects of both arms were instructed to remain in the hospital under supervision for 16 hours and return 3 days after device placement for the first follow-up visit. About 400 mg of Ibuprofen was administered post PrePex placement only. On day 7, the device and foreskin were removed. The treated area was dressed with sterile gauze for 2 days. On day 9, the subject returned for a follow-up visit, and the dressing was removed. The subject returned for a weekly visits (days 14, 21, 28, 35, 42, 49, 56, and 63) for 8 weeks (total of 9 weeks from placement). Participants Participants were eligible if they were male, aged years, and a resident of Bugesera District in Rwanda, the lower age of 21 was selected because in Rwanda this age is considered as legally adult for clinical studies, the upper age of 54 was selected according to the target upper age of the Ministry of Health for nation-wide MC campaign. A localized demand creating effort was done around the Hospital area, calling men to participate in the study. Men who arrived to the hospital arrived with the intention to be circumcised as part of the study and only then went through inclusion exclusion investigation and HIV testing. Subjects had to be uncircumcised, wanted to be circumcised, agree to being circumcised by either study method, and be capable of understanding study procedures and requirements. In addition, subjects had to agree to abstain from sexual intercourse for 9 weeks, agree to return to the health care facility for follow-up visits, and agree to anonymous video and photographs of the procedure and follow-up visits. Exclusion criteria for the trial included active genital infection, anatomic abnormality, or according to the investigator, any condition preventing the subject from being circumcised; any of the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, and epispadias; known bleeding/coagulation abnormality, or uncontrolled diabetes; abnormal penile anatomy or any penile diseases; refusal to take HIV test; or any subject considered by the investigator to be an unsuitable candidate, such as mental condition or inability to return for follow-up visits. After signing the informed consent form (ICF), patients were enrolled into the trial by randomly assigning them to 1 of the 2 arms. All subjects went through the national voluntary counseling and testing program for HIV after enrollment to the study. Surgical MC Arm All surgical MC procedures used the dorsal slit method 12 performed by the same surgeon who was highly experienced in this surgical technique for adults. Surgery was performed under local anesthesia according to WHO guidelines. 8 For light bleeders, the surgeon used a monopolar diathermia device; for heavy bleeders, a knot with a stitching thread was made. The first follow-up visit was 1 week later with subsequent visits per the nonsurgical arm. Outcomes The primary endpoint was total MC skin-to-skin procedure time (Table 1). Secondary outcomes were as follows: procedure preparation time; clinical adverse event (AE) rates; surgical procedure-related and device-related incident rates; expected side effects; pain at key time points and during erection on day 3 and day 9; loss of productivity; patient satisfaction; and time to complete healing (Table 1). Time intervals were measured using a stopwatch; as a backup, a video of each procedure was recorded. Sample Size It was determined that a sample size of 144 would provide 80% power with alpha set to 0.05 based on a mean PrePex time of up to 10 minutes, reference procedure time of 18 minutes. Using an allocation ratio of 2:1 (PrePex/reference procedure) 10 and a dropout rate of ;25%, the target sample size was set to 180 subjects Ó 2012 Lippincott Williams & Wilkins
3 J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 HIV Prevention TABLE 1. Definition of End Points Endpoint Nonsurgical procedure time* (min) Surgical procedure time* (min) Nonsurgical preparation time (min) Surgical preparation time (min) Clinical adverse event rates Device-related and procedure-related incident rates Expected side effects Pain assessment at key intervals (VAS scale) Pain on days 3 and 9 during erection (VAS scale) Loss of productivity (mean hrs) Patient satisfaction Time to complete healing (wks) *Primary endpoint. VAS, visual analog scale. Definition Device placement time + device removal time (placement time starts when the device placement ring is placed over the penis until the time that the verification thread was removed and the patient got up From first cut to last suture Room preparation, pull down pants/shorts, disinfecting, draping, sizing, and wound dressing Sterile field and environment preparation, dressing subject for surgery, dressing staff for surgery, anesthesia, disinfecting, draping, and wound dressing Any adverse event during the study period Any adverse event judged by the surgeon or treating clinician related or likely to be related to surgical or nonsurgical MC Clinical findings that are expected in a normal circumcision procedure, including localized edema, oozing, and clear exudate Subjective pain was assessed by numeric pain VAS scale during anesthesia/placement, 1, 2, 3, 4, 8, and 16 hours post procedure, during and immediately after PrePex removal PrePex and surgical subjects pain during erection was gathered on day 3, additional measurement was performed only for the PrePex subjects on day 9 (2 days after removal) Lost working/productivity hours after PrePex placement was assessed up to day 9; for surgical patients, it was assessed up to day 7. Days of procedure were not included in the assessment Patients were asked the following: (1) Are you satisfied with the aesthetic of your circumcision result? If not, why not? (2) Would you recommend the procedure you had to friends or relatives? If yes, what benefits would you share with them about the procedure you had? Time to complete healing was calculated from end of procedure until time when all scores were 0 as follows: drainage from incision (score 0 2); epithelialization (score: 0 3); granulation of tissue (score: 0 2); edema (score: 0 1) Randomization, Sequence Generation, Allocation Concealment, Masking and Implementation A randomized number table was created by the study PI using the RAND algorithm in Excel (Microsoft Corp, Redmond, WA) in which each randomized number was distributed between and To achieve an allocation ratio of 2:1, each random number below was assigned to the surgical arm and each number higher than was assigned to the PrePex arm. Randomized numbers and study arms were marked with study numbers (1, 2, 3, etc.) and notes were prepared containing the study number, random number, and assigned intervention by the study principal investigator. Study envelopes each containing the folded note were prepared, sealed, and the study number written on each before enrollment by the principal investigator solely who was not involved in the enrollment and allocation process. It was validated that assigned intervention could not be seen through the sealed envelope. Each subject who met the inclusion exclusion criteria, signed the informed consent, and passed screening was enrolled by co-investigator and assigned a study number, which was documented. Only then the subject received a sealed envelope from a co-investigator with his study number on it. The subject opened the envelope in front of the co-investigator and intervention assignment was documented, the randomization note was attached to the study file. Statistical Methods Statistical analyses were performed using SAS v 9.2 statistical software (SAS Institute, Cary NC). Although primary outcome analysis was originally intended to be intention to treat, the placement time for 1 patient in the PrePex arm was not recorded, therefore it was decided to proceed with a as treated analysis with 1 missing subject. Categorical parameters were summarized by frequencies and percentage, whereas quantitative variables were described using the mean, median, SD, and range. Nominal categorical parameters were analyzed by Fisher exact/x 2 tests, ordinal categorical parameters by the Wilcoxon rank sum test, and continuous variables by t test. Logistic regression was used to compare rates adjusted for major demographic covariates. An alpha of 0.05 was used to define statistical significance. Protocol Amendment The original protocol and ICF called for a stay of 4 6 hours after the procedure. However, patients did not return for their 4 6 hours follow-up after the procedure, making it difficult to monitor their post procedure pain levels. As a result, after 38 enrolled subjects, it was decided to continue the study by incorporating an overnight stay (16 hours) for all subjects with a nurse monitor who administered pain medication on demand to better ensure their safety and well being. Patients subsequently verbally notified and consented to the overnight stay before the procedure was conducted. A WHO MC Technical Advisory Group retroactively requested that these first 38 subjects be included in the final analysis because all 9-week safety data were collected anyway. Therefore, primary outcome analysis includes data on 217 patients. Sixteen-hour pain Ó 2012 Lippincott Williams & Wilkins 51
4 Mutabazi et al J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 analysis and patient satisfaction data occurred starting with the 39th patient. RESULTS Participant Flow Men that arrived to the Hospital with intention to be circumcised were asked if they will consider joining the study and then screened, including HIV test. Of 265 candidates screened, 226 were found eligible. There were 8 cases of subjects that were randomized, but before MC the treating physician found that they do not meet the inclusion exclusion criteria, and one subject who did not show up for MC. In total, 217 subjects were eligible and treated; 144 were randomized to the PrePex nonsurgical arm and 73 to the surgical arm (Fig. 1 for detailed description). Eight patients were lost to follow-up for the last scheduled visit (1 in the surgical arm and 7 in the PrePex arm). Recruitment, Baseline Data, and Numbers Analyzed The entire study was carried out between February 17 and April 8, All subjects were HIV negative. The mean age of subjects in the 2 arms was similar (PrePex: 26 years, SD: 5.17; surgical MC: 24 years, SD: 4.10). For the primary per protocol analysis, 73 patients in the surgical arm and 143 patients in the PrePex arm (For 1 subject, we failed to document the PrePex placement time) were analyzed. The number of subjects who were analyzed for each of the secondary outcomes are listed in Table 2. Outcomes The mean PrePex skin-to-skin procedure time, combining placement and removal, was significantly shorter at 3.1 minutes (SD: 1.1) compared with a mean surgical skinto-skin MC time of 15.4 minutes (SD: 3.1) (P, ). Mean PrePex preparation time was also significantly faster at 3.4 minutes (SD: 1.13) in comparison to the mean surgical MC preparation time of 8.8 minutes (SD: 1.97) (P, ). In the PrePex arm, there were zero device-related AEs and 4 non device-related AEs (no subject had more than 1 AE) (Table 3). In the MC surgical group, there were 7 AEs related to surgery and 1 AE unrelated to surgery (Table 3); in each arm, the scrotal abscess was determined as unrelated due to it s distance from the MC site and lack of evidence of laceration and or dermal damage before the abscess appeared. All AEs were resolved. The total AEs rates (related and unrelated) were 2.7% in the PrePex arm compared with 11% in the MC surgical arm (P = 0.029). Sixteen percent of PrePex subjects experienced expected side effects, the most common which was localized edema, compared with 45% of subjects in the surgical group (P, ) (Table 3). Side effects were defined as regular expected appearance of a healing MC wound and included very common signs such as clear exudates, localized mild edema in the wound area, oozing, and FIGURE 1. Flow chart diagram details the disposition of all study participants Ó 2012 Lippincott Williams & Wilkins
5 J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 HIV Prevention TABLE 2. Sample Size Per Endpoint Outcome Surgical (n) PrePex (n) Notes Procedure preparation time One PrePex subject time was not documented Clinical AE rates Surgical procedure-related AE rates, device-related AE rates, expected side effects Loss of productivity Pain at key time points Some subjects data was not gathered by coordinators Pain during erection Some subjects could not determine the pain Patient satisfaction Some subjects did not cooperate with questionnaires Time to complete healing Some subjects missed their last visit slough. All AEs and side effects were categorized and graded by the study investigators and relied on recommendations from the WHO framework. 10 Procedure pain was measured by visual analog scale (VAS), by presenting to subjects a scale of 0 10 where each level has a relevant faces with increasing degrees of pain and description in words and asking them to select the most representative level. Pain by VAS is summarized in Table 4. Mean pain level by subject was higher at time of MC anesthesia administration compared with PrePex placement with no anesthesia (2.4 vs. 0.8; Table 4). Pain levels 1 8 hours after procedures in the surgical arm were lower than in the PrePex arm. The 2 points of higher pain in the PrePex arm were 1 hour post PrePex procedure (mean 5.6 SD 1.8) and during PrePex removal (mean 4.7 SD 1.9) whichlasted2 5 seconds, and decreased to 1.4 immediately after removal. Pain during erection on day 3 in the surgical arm was 5.2 (SD: 2.2) compared with 2.5 (SD: 1.8) for the PrePex arm, additional pain during erection was gathered for the PrePex arm on day 9 [2 days after removal and resulted in 1.9 (SD: 1.5)]. The pain scores during erection for the surgical group was significant higher compared with the PrePex group (P, ). On average, a patient in the MC surgical arm lost significantly more days (1.15 days) compared with a patient in the PrePex arm (0.07 days) (P, ). Six weeks after circumcision, there was no significant difference in satisfaction of subjects in both arms, 91 of 92 patients (99%) in the PrePex group were satisfied with the aesthetics of circumcision compared with 55 of 55 patients (100%) in the surgical group. Ninety-one of 92 (99%) patients in the PrePex group would recommend the procedure compared with 54 of 55 patients (98%) in the surgical group. Six weeks after circumcision, they were asked if they would recommend the MC procedure to their friend and why. The key reasons selected by the PrePex subjects were the cosmetic outcome and the hygiene benefits. The key reasons selected TABLE 3. Clinical Adverse Events and Expected Side Effects Study Arm Frequency Adverse Event Severity Relation Action Taken Outcome Clinical adverse events PrePex 3 Burn blisters on scrotum due to undiluted chlorohexidine PrePex 1 Scrotal abscess (Day 21, 2 weeks after removal) Mild Not device related; related to erroneous preparation Paracetamol administration Moderate Not device related Incision, drainage, and antibiotics Resolved Resolved Surgical 1 Productive exudates Mild Surgery related Dressing applied Resolved Surgical 2 Diffuse edema Mild Surgery related None Resolved Surgical 4 Bleeding Mild: 2 Surgery related In 2 cases, pressure was Resolved Moderate: 2 applied; in 2 cases, suturing was required Surgical 1 Scrotal abscess (day 21, 3 weeks after surgery) Moderate Not related to surgery Incision and drainage Resolved Action taken PrePex arm Surgical MC arm n % n % Expected side effect Oozing None Localized edema None Clear exudate None All side effects Ó 2012 Lippincott Williams & Wilkins 53
6 Mutabazi et al J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 TABLE 4. Mean Pain Levels During Various Procedure Points Study Arm During Anesthesia or Placement +1 Hour During PrePex Removal Immediately Post PrePex Removal Pain During Erection Day3 Pain During Erection Day 9 Surgical 2.4 (0.9) 3.8 (2.1) 2.3 (1.6) 1.4 (1.5) 0.9 (1.3) 0.7 (1.2) 0.9 (1.5) NA NA 5.2 (2.2) NA PrePex 0.8 (1.2) 5.6 (1.8)* 4.1 (1.9) 2.8 (1.8) 1.9 (1.5) 1.1 (1.6) 0.3 (0.8) 4.7 (1.9) 1.4 (1.6) 2.5 (1.8) 1.9 (1.5) *See Discussion section. Lasts 2 5 seconds upon inner ring extraction. SD, standard deviation; NA, not available. by the surgical subjects were that the healing process is fast and that the hygiene benefits. The number of days required for complete healing in the PrePex group was 31 days post device removal (SD: 12.1) compared with 23 days post surgery (SD: 7.50) for the surgical group (P, ). DISCUSSION The low or no pain reported by subjects during the placement of the PrePex on the penis can be attributed to the fact that PrePex is designed in a manner that allows controlled radial elastic pressure that does not crush the foreskin to achieve hemostasis, different than all other devices which require anesthesia at placement After this comparative study, a yet to be published study examined ways to reduce the discomfort 1 hour post placement. It was discovered that the discomfort is superficial and not deep. Therefore, we studied applying 1g of Lidocaine 5% dermal anesthetic cream at placement. The cream takes about minutes to kick in, and therefore it averted the 1-hour post placement discomfort. The anesthetic cream is now part of the standard PrePex procedure and placement of the device is pain free. PrePex, the nonsurgical MC, was statistically significantly faster (almost 5 times) compared with surgical MC as measured by procedure time and had significantly fewer AE. Surgical preparation time was 2.5-fold longer compared with PrePex preparation time also a statistically significant result. The surgical procedure time in our study (15.4 minutes) was below typical of conventional surgical procedures. 13,16 19 Our finding that nonsurgical MC took significantly less time than surgical MC is especially noteworthy, considering that the average surgical MC procedure time in our study was less than the time reported in the WHO MOVE model. 7 The MOVE model s shortest surgical circumcision time was 19 minutes, whereas the average time for surgical MC in our study was 15 minutes, we cannot speculate the reasons for those time differences. PrePex time was shorter than other reported MC devices used in developing countries when preparation and device placement and removal time are taken into account. 14,15 Our study was performed in a district hospital, but we have reason to believe that it is applicable in the same manner in any other clean clinical setting such as a classroom or tent, as the room had no special sterile settings. In the PrePex group, subjects reached first complete healing 31 days after the device removal (38 days from initial device placement), whereas the surgical arm subjects reached complete healing after 23 days, which represents an advantage to the surgical technique, this finding should be considered in the decision to use the nonsurgical device. A second consecutive healing verification visit was conducted in both arms. WHO suggests that patients may resume to protected sex (using condoms) 6 weeks post procedure, which would be applicable to both the device and surgical arm. During the study, all men were asked weekly if they were abstaining from sex, and all complied with the WHO voluntary counseling and testing program suggestions. The biggest obstacle to scale-up MC in Rwanda is lack of surgeons and surgical infrastructure. A nonsurgical technique may help change current government policies and facilitate task shifting of MC to nurses. Rwanda has embarked upon a field study to test the safety profile of PrePex in the hands of nurses (clinicaltrials.gov NCT ) in large numbers as the third and finalstepoutlinedbywho. 7 A 3 days training course should be sufficient to enable low cadre nurses with no experience with PrePex MC to become PrePex MC Experts and perform safe and efficient PrePex procedures. Only 3% of the eligible men for MC in Africa have been reached since the WHO and UNAIDS issued their MC HIV prevention suggestions. 20,21 The findings of our study demonstrates that PrePex has the potential to transform circumcision programs in resource-limited countries prevalent in sub-saharan Africa and can likely be deployed by nurses rather than requiring surgeon or physician deployment. The procedure has been scientifically validated as safe, effective, and faster than surgical technique. The procedure is bloodless, requires no injected anesthesia, no sutures, and no sterile settings and accordingly has the potential to enable rapid scale-up of MC in Rwanda in sub-saharan Africa. Based on the results of our study, Rwanda officially approved the device for use in the country and is updating its national scale-up plan to use PrePex instead of the surgical method. ACKNOWLEDGMENTS Dr Marissa Carter (Strategic Solutions, Inc, Cody, WY) edited the article and has also given permission to have her name and information included in the acknowledgment Ó 2012 Lippincott Williams & Wilkins
7 J Acquir Immune Defic Syndr Volume 61, Number 1, September 1, 2012 HIV Prevention REFERENCES 1. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized controlled trial. Lancet. 2007;369: Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369: Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2:e Mills E, Cooper C, Anema A, et al. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med. 2008;9: Auvert B, Taljaard D, Rech D, et al. Effect of the Orange Farm (South Africa) male circumcision roll-out (ANRS-12126) on the spread of HIV. Presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17 20, 2011, Rome, Italy. Abstract WELBC WHO/UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. Presented at: WHO/UNAIDS Technical Consultation; 6 8 March 2007; Montreux, Switzerland. Available at: Accessed September 19, World Health Organization. Considerations for implementing models for optimizing the volume and efficiency of male circumcision services. February Available at: documents/mc_move_2010_web.pdf. Accessed September 19, World Health Organization. Manual for male circumcision under local anesthesia, version 2.5C. January Available at: int/hiv/pub/malecircumcision/who_mc_local_anaesthesia.pdf. Accessed September 19, Ministry of Health (MOH) [Rwanda], National Institute of Statistics of Rwanda (NISR), and ICF Macro Rwanda Interim Demographic and Health Survey Calverton, MD: MOH, NISR, and ICF Macro. Available at pdf. Accessed September 19, World Health Organization. Framework for clinical evaluation of devices for adult male circumcision. Available at: cumcision/framework_devices/en/index.html. Accessed September 22, Bitega JP, Ngeruka ML, Hategekimana T, et al. Safety and efficacy of the PrePex device for rapid scale up of male circumcision for HIV prevention in resource-limited settings. J Acquir Immune Defic Syndr. 2011;58:e127 e Harahap M, Siregar AS. Circumcision: a review and a new technique. J Dermatol Surg Oncol. 1988;14: Decastro B, Gurski J, Peterson A. Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device. Urology. 2010;76: Senel FM, Demirelli M, Pekcan H. Mass circumcision with a novel plastic clamp technique. Urology. 2011;78: Masson P, Li PS, Barone MA, et al. The ShangRing device for simplified adult circumcision. Nat Rev Urol. 2010;7: Lissouba P, Taljaard D, Rech D, et al. A model for the roll-out of comprehensive adult male circumcision services in African low-income settings of high HIV incidence: the ANRS Bophelo Pele Project. PLoS Med. 2010;7:e Buwembo DR, Musoke R, Kigozi G, et al. Evaluation of the safety and efficiency of the dorsal slit and sleeve methods of male circumcision provided by physicians and clinical officers in Rakai, Uganda. BJU Int. 2012;109: Kiggundu V, Watya S, Kigozi G, et al. The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai, Uganda. BJU Int. 2009;104: Vaos G. Circumcision with the Nd:YAG laser contact technique compared with conventional surgery. Photomed Laser Surg. 2004;22: Obstacles slow an easy way to prevent HIV in men. New York Times; September 26, 2011; Available at: health/27circumcision.html?pagewanted=all. Accessed March 5, UNAIDS. International partners call for accelerated access to voluntary medical male circumcision in eastern and southern Africa. December 5, Available at: releaseandstatementarchive/2011/december/ prvmmc/. Accessed April 29, Ó 2012 Lippincott Williams & Wilkins 55
Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana
SUPPLEMENT ARTICLE Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana Adrian M. Musiige, MD, MPH,* Tigistu A. Ashengo, MD, MPH, Galina Stolarsky,
More informationSafety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe
SUPPLEMENT ARTICLE Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe Webster Mavhu, PhD,* Karin Hatzold, MD, MPH,
More informationTime to Complete Wound Healing in HIV-Positive and HIV-Negative Men following Medical Male Circumcision in Kisumu, Kenya: A Prospective Cohort Study
Time to Complete Wound Healing in HIV-Positive and HIV-Negative Men following Medical Male Circumcision in Kisumu, Kenya: A Prospective Cohort Study John H. Rogers 1 *, Elijah Odoyo-June 2,3, Walter Jaoko
More informationSafety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia
SUPPLEMENT ARTICLE Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia Paul Feldblum, PhD, MSPH,* Neil Martinson,
More informationHIV is the primary exclusion criterion in a PrePex male circumcision device introductory study in Mozambique
HIV is the primary exclusion criterion in a PrePex male circumcision device introductory study in Mozambique SA HIV Clinicians Society Conference 2014 Ferreira, T*; Mahomed, M*; Bossemeyer, D*; Nhambi,
More informationFactors Associated with the Early Resumption of Sexual Activity Following Medical Male Circumcision in Nyanza Province, Kenya
AIDS Behav (2012) 16:1173 1181 DOI 10.1007/s10461-011-0073-1 ORIGINAL PAPER Factors Associated with the Early Resumption of Sexual Activity Following Medical Male Circumcision in Nyanza Province, Kenya
More informationSupplemental Digital Content
Supplemental Digital Content 1 Methodology for estimating the contribution of identifiable HIV incidence among stable HIV-1 sero-discordant couples to total HIV population-level incidence We based our
More informationTim Farley, Ph.D. Nyon, Switzerland Consultant to WHO/HIV Department 26 September 2012
MALE CIRCUMCISION DEVICES STATUS AND RESEARCH UPDATE Tim Farley, Ph.D. Nyon, Switzerland Consultant to WHO/HIV Department 26 September 2012 26 September 2012 Sigma3 Services Slide 2 Outline Male circumcision
More informationBuilding the capacity to Deliver Early Infant Male Circumcision services in Rwanda: Lessons learnt
Building the capacity to Deliver Early Infant Male Circumcision services in Rwanda: Lessons learnt Presenter: Placidie Mugwaneza Prevention Unit/HIV Division Rwanda Biomedical Center 1 Outline Introduction
More informationChapter 7: Management of Adverse Events and Side Effects
Chapter 7: Management of Adverse Events and Side Effects Learning Objectives At the end of the session, participants should be able to: Describe potential adverse events (AEs) and side effects of PrePex
More informationS20 Barone et al J Acquir Immune Defic Syndr Volume 72, Supplement 1, June 1, 2016
SUPPLEMENT ARTICLE Men s Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and
More informationPrimary Coverage. The Benefits of Circumcision Operation Principle Academic Article Circumstapler Advantages Operating Procedure Post Operation Caring
Circumstapler Primary Coverage The Benefits of Circumcision Operation Principle Academic Article Circumstapler Advantages Operating Procedure Post Operation Caring The Benefits of Circumcision? There is
More informationTool C Client Record Review
Tool C Client Record Review Voluntary Medical Male Circumcision (VMMC) Tool C Client Record Review External Quality Assurance (EQA) Site Name: Reviewer s Name: Date: This Tool (C) is used to verify the
More informationEDITORS. National Guidance for Voluntary Male Circumcision in Kenya
EDITORS Dr. Ibrahim Mohammed - NASCOP Dr. Peter Cherutich - NASCOP Dr. Naomi Bock - CDC Dr. Kawango Agot - UNIM Mr. Charles Mwai - NACC Dr. Rex Mpazanje - WHO Suggested Citation National AIDS/STD Control
More informationINTRODUCTION. 204 MCHIP End-of-Project Report
Redacted INTRODUCTION Three randomized clinical trials determined unequivocally that male circumcision (MC) reduces female-to-male HIV transmission by approximately 60%. 1,2,3 Modeling studies demonstrate
More informationCircumcision. Multimedia Health Education. Disclaimer
Disclaimer This movie is an educational resource only and should not be used to manage genitourinary health. All decisions about undergoing must be made in conjunction with your Physician or a licensed
More informationAPPENDIX 4: ADVERSE EVENT CLASSIFICATIONS AND DEFINITIONS: POST- OPERATIVE PERIOD AFTER DISCHARGE FROM VMMC CLINIC OR DURING OR AFTER DEVICE REMOVAL
APPENDIX 4: ADVERSE EVENT CLASSIFICATIONS AND DEFINITIONS: POST- OPERATIVE PERIOD AFTER DISCHARGE FROM VMMC CLINIC OR DURING OR AFTER DEVICE REMOVAL ADVERSE EVENT MILD MODERATE SEVERE BL: Bleeding DD:
More informationThe impact of male circumcision on the female-to-male transmission of HIV : Results of the intervention trial : ANRS 1265
The impact of male circumcision on the female-to-male transmission of HIV : Results of the intervention trial : ANRS 1265 Bertran Auvert, INSERM, UVSQ, AP-HP, France Adrian Puren, NICD, South Africa Dirk
More informationMale Circumcision in Zambia: National Operational Plan for Scale-up
Male Circumcision in Zambia: National Operational Plan for Scale-up PEPFAR/WHO/UNAIDS Consultative Meeting Johannesburg, September 28 th, 2012 Dr. Daniel Makawa, National MC Coordinator Background Zambia
More informationCircumcision PLANNING AND PREPARATION
Surg Ill Article surgery illustrated ELDER Circumcision Jack S. Elder Department of Urology, Henry Ford Health System and Vattikuti Urology Institute, Detroit, Michigan, USA PLANNING AND PREPARATION In
More informationHEY CHARLES, I TOOK YOUR ADVICE AND WENT FOR MC! GREAT, BUT HERE is SOME IMPORTANT info YOU NEED TO REMEMBER! TAKE HOME BOOKLET
HEY CHARLES, I TOOK YOUR ADVICE AND WENT FOR MC! GREAT, BUT HERE is SOME IMPORTANT info YOU NEED TO REMEMBER! TAKE HOME BOOKLET You ve made an important choice to go for MC. There are two important issues
More informationVoluntary Medical Male Circumcision (VMMC) Training Kit. Facilitators Guide
Voluntary Medical Male Circumcision (VMMC) Training Kit Facilitators Guide 2017 Voluntary Medical Male Circumcision (VMMC) Training Kit Facilitators Guide Copyright 2017 All rights reserved. No part of
More informationCircumcision bleeding complications: Neonatal intensive care infants compared to. those in the normal newborn nursery
Circumcision bleeding complications: Neonatal intensive care infants compared to those in the normal newborn nursery Abigail R. Litwiller MD 1, David M. Haas MD, MS 2 1 Department of OB/GYN, University
More informationVoluntary Medical Male Circumcision Summary of Devices Costing and Modeling Studies
Voluntary Medical Male Circumcision Summary of Devices Costing and Modeling Studies Emmanuel Njeuhmeli, MD, MPH, MBA Sr. Biomedical Prevention Advisor Office of HIV/AIDS USAID Washington 6 studies published
More informationReflec%ons on the Role of Discordant Couples and the HIV Epidemic. Implementa%on Science and Male Circumcision in Rakai
Reflec%ons on the Role of Discordant Couples and the HIV Epidemic Implementa%on Science and Male Circumcision in Rakai Ron Gray & Maria Wawer Johns Hopkins University Discordant couples, why are they important?
More informationSafe Male Circumcision
Ministry of Health Safe Male Circumcision Discussion Set FACILITATOR S GUIDE This guide will help you use the Safe Male Circumcision (SMC) Discussion Set to provide basic information on the benefits of
More informationUSING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa
USING MATHEMATICAL MODELING FOR POLICY AND STRATEGIC PLANNING A case study of VMMC Scale-Up in Eastern and Southern Africa INTEREST 2018 Kigali, Rwanda Emmanuel Njeuhmeli, MD, MPH, MBA Senior Medical Advisor
More informationTeche Regional Urology David C. Benson, MD, FACS 1302 Lakewood Drive Suite 100 Morgan City, La
VASECTOMY PATIENT INFORMATION I. Purpose of the operation The intent of the operation, known as bilateral partial vasectomy, is to render you sterile (i.e. unable to cause a pregnancy in a female partner).
More informationAsia Pacific Aesthetic Medicine (APAM) Vol 2. Bigger in all sense: Penile dual augmentation surgery Today, a man can modify the size and shape of his
Asia Pacific Aesthetic Medicine (APAM) Vol 2. Bigger in all sense: Penile dual augmentation surgery Today, a man can modify the size and shape of his penis using procedures introduced by cosmetic/plastic
More informationOverview of the current evidence on male circumcision and HIV prevention
Overview of the current evidence on male circumcision and HIV prevention Overview of the current evidence on male circumcision and HIV prevention Male circumcision in the emerging HIV prevention technology
More information1/5. Introduction. Primary endpoint Time to reach readiness for closure by surgical intervention or left for closure by secondary intention
1/5 Introduction Materials and methods Animal studies show that intermittent NPWT has potential to increase the rate of granulation tissue formation compared with adjustable intermittent (AI) NPWT 1 However,
More informationHIV Prevention. Recent Advances and Implications for the Caribbean
HIV Prevention Recent Advances and Implications for the Caribbean Chris Behrens, MD CCAS/CHART Conference Barbados, August 2010 Cases 200 180 160 140 120 100 80 60 40 20 0 Year HIV Cases AIDS Cases HIV
More informationTHE RELATIONSHIP BETWEEN MALE CIRCUMCISION AND HIV/AIDS IN LESOTHO. Nthatisi Ramaema
THE RELATIONSHIP BETWEEN MALE CIRCUMCISION AND HIV/AIDS IN LESOTHO Nthatisi Ramaema ABBREVIATIONS AND ACRONYMS AIDS HIV CHAL LDHS MC MOHSW Acquired Immune Deficiency Syndrome Human Immune Deficiency Virus
More informationMale circumcision does NOT reduce penile sensitivity. Ira D. Sharlip, M.D. Clinical Professor of Urology UCSF
Male circumcision does NOT reduce penile sensitivity Ira D. Sharlip, M.D. Clinical Professor of Urology UCSF Does male circumcision affect sexual function, sensitivity or satisfaction? a Systematic Review.
More informationUsing Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire
Using Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire Data Demand and Information Use Case Study Series MEASURE Evaluation www.cpc.unc.edu/measure Data Demand and
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Penile Conditions - Surgical Opinion and Treatment Policy including Circumcision in all male patients over the age of 18 years Prior Approval Policy Date
More informationSingle-Arm Evaluation of the AccuCirc Device for Early Infant Male Circumcision in Botswana
RAPID COMMUNICATION Single-Arm Evaluation of the AccuCirc Device for Early Infant Male Circumcision in Botswana Rebeca M. Plank, MD, MPH,*ft Kathleen E. Wirth, ScD t Nnamdi 0. Ndubuka, MB, BS, Dip HIV
More informationReview Article. The Impact of Male Circumcision on HIV Transmission. Sean M. Doyle,* James G. Kahn,* Nap Hosang* and Peter R.
Review Article The Impact of Male Circumcision on HIV Transmission Sean M. Doyle,* James G. Kahn,* Nap Hosang* and Peter R. Carroll, From the Department of Urology (SMD, PRC), Philip R. Lee Institute for
More informationInformation for Patients. Phimosis. English
Information for Patients Phimosis English Table of contents What is phimosis?... 3 How common is phimosis?... 3 What causes phimosis?... 3 Symptoms and Diagnosis... 3 Treatment... 4 Topical steroid...
More informationThe Safety of Adult Male Circumcision in HIV- Infected and Uninfected Men in Rakai, Uganda
The Safety of Adult Male Circumcision in HIV- Infected and Uninfected Men in Rakai, Uganda Godfrey Kigozi 1, Ronald H. Gray 2*, Maria J. Wawer 2, David Serwadda 3, Frederick Makumbi 3, Stephen Watya 4,
More informationVASECTOMY COUNSELING If you are thinking of having a vasectomy, there are some important things you should know before the vasectomy is done.
VASECTOMY COUNSELING If you are thinking of having a vasectomy, there are some important things you should know before the vasectomy is done.* Vasectomy is intended to be a permanent form of contraception.
More informationBefore Your Vasectomy
Before Your Vasectomy WHAT TO KNOW BEFORE YOUR PROCEDURE What is a vasectomy? A vasectomy is a simple procedure that makes a man permanently sterile. This means that he cannot get a woman pregnant. After
More informationColloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
More informationMale Circumcision and HIV in Zambia
Male Circumcision and HIV in Zambia 66 Kasonde Bowa 1 MSc,M.Med,FRCS, Mainza Lukobo 2, BSc, DrPH 1 University Teaching Hospital Lusaka Zambia, 2 State University of Chicago, Illinois Correspondence to:
More informationPrevalence and acceptability of male circumcision in South Africa
Prevalence and acceptability of male circumcision in South Africa Leickness Simbayi, Karl Peltzer & Dorina Onoya Human Sciences Research Council, South Africa Presentation at the 10 th AIDS Impact Conference
More informationMale Circumcision and HIV Prevention: Operations Research Implications An International Consultation June 2007 Safari Park Hotel, Nairobi, Kenya
Page 1 Male Circumcision and HIV Prevention: Operations Research Implications An International Consultation 21-22 June 2007 Safari Park Hotel, Nairobi, Kenya Page 2 Table of Contents: 1. Executive Summary--page
More informationPRECOURSE QUESTIONNAIRE ANSWER KEY
PRECOURSE QUESTIONNAIRE ANSWER KEY USING THE INDIVIDUAL AND GROUP ASSESSMENT MATRIX The precourse questionnaire is not intended to be a test but rather an assessment of what the participants, individually
More informationThe meeting is a follow-up to the Male Circumcision Operations Research meeting held in June 2007 and the MC Move meeting held April 2009.
Purpose & General Objective The two-day meeting will bring together individuals and groups working to expand male circumcision services for HIV prevention following the March 2007 WHO/UNAIDS recommendation
More informationMale Circumcision and HIV Prevention. Operations Research Implications. HIV/AIDS Department. Report of An International Consultation
HIV/AIDS Department Male Circumcision and HIV Prevention Operations Research Implications Report of An International Consultation 21 22 June 2007, Nairobi, Kenya Male Circumcision and HIV Prevention: Operations
More informationThe bell is gently and slowly removed (the foreskin may naturally form an adhesion to
Circumcision Definition: The removal of the foreskin anatomy of the penis; to cut off the clitoris and sometimes the labia of a female. This document only covers male circumcision. Male Anatomy: The foreskin,
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationMinistry of Health. National Male Circumcision Strategy and Implementation Plan
Ministry of Health National Male Circumcision Strategy and Implementation Plan 2010-2020 ii Foreword According to the 2007 ZDHS a reduction in the prevalence of HIV has been noted, however despite the
More informationFAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030
Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December
More informationThe Long Term Efficacy of Medical Male Circumcision against HIV Acquisition
The Long Term Efficacy of Medical Male Circumcision against HIV Acquisition 1 Supriya D. Mehta, MHS, PhD 2 Stephen Moses, MD, MPH 3 Kawango Agot, PhD 4 Elijah Odoyo-June, MBCHB, MSc 1 Hong Li, MS 2 Ian
More informationPerceptions and Beliefs of University and College Students Towards Male Circumcision in Lusaka
ORIGINAL PAPER Perceptions and Beliefs of University and College Students Towards Male Circumcision in Lusaka 1, 2 2 2 Chama Chanda *, Rosemary Likwa-Ndonyo, Selestine Nzala, and Oliver Mweemba 1 National
More informationHypospadias Information leaflet for parents Child Health Directorate
Hypospadias Information leaflet for parents Child Health Directorate Please note that this information leaflet is designed to give an overview of the experience that you and your son will go through during
More informationRenewing Momentum in the fight against HIV/AIDS
2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly
More informationo Changes since 1999 policy statement and 2005 update
Circumcision A Review of AAP Task Force Recommendations from August of 2012 Objectives Review AAP recommendations on circumcision o Changes since 1999 policy statement and 2005 update Be able to discuss
More informationrepresenting 45% and 35% of VMMC volumes clients in Zambia and Zimbabwe, respectively. An assumed 93% of adults were medically eligible.
SUPPLEMENT ARTICLE Evaluating Opportunities for Achieving Cost Efficiencies Through the Introduction of PrePex Device Male Circumcision in Adult VMMC Programs in Zambia and Zimbabwe Lyndsey Vandament,*
More informationBOSTWANA KEY. Controlling the Pandemic: Public Health Focus
BOSTWANA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people worldwide
More informationThe outlook for hundreds of thousands adolescents is bleak.
Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds
More informationCircumcision Excerpted from Gentle Baby Care by Elizabeth Pantley
Male Circumcision Circumcision Dr. Morris Elstein is the only doctor (that we are aware of) who will perform this surgery on your homebirthed son. He is not only a doctor but also, a special religious
More informationDownloaded from:
Hallett, TB; Alsallaq, RA; Baeten, JM; Weiss, H; Celum, C; Gray, R; Abu-Raddad, L (2011) Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact
More informationFEASIBILITY OF MEDICAL MALE CIRCUMCISION IN NYANZA PROVINCE, KENYA. C. L. MATTSON, R. MUGA, R. POULUSSEN, T. ONYANGO and R. C.
230 EAST AFRICAN MEDICAL JOURNAL May 2004 East African Medical Journal Vol. 81 No. 5 May 2004 FEASIBILITY OF MEDICAL MALE CIRCUMCISION IN NYANZA PROVINCE, KENYA C. L., Mattson, MS., Division of Epidemiology
More informationCOSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them.
COSTA RICA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people
More informationProgress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa
SUMMARY REPORT Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa January December 2012 Table of contents List of acronyms 2 Introduction 3 Summary
More informationInformation Package on Male Circumcision and HIV Prevention
Insert Introduction Male circumcision is the surgical removal of all or part of the foreskin of the penis. It is one of the oldest and most common surgical procedures worldwide, undertaken for religious,
More informationHIV Viral Load Testing Market Analysis. September 2012 Laboratory Services Team Clinton Health Access Initiative
HIV Viral Load Testing Market Analysis September 2012 Laboratory Services Team Clinton Health Access Initiative Agenda Background on Viral Load Testing Growth of Global Viral Load Market Factors Impacting
More informationFramework for Clinical Evaluation of Devices for Adult Male Circumcision
Framework for Clinical Evaluation of Devices for Adult Male Circumcision February 2011 Executive Summary Male circumcision has been shown to reduce the risk of HIV infection in men and is recommended by
More informationWhite Paper. Wound Closure
White Paper Table of Contents 1. Introduction... 3 2. Primary Endpoint:... 3 3. Secondary Endpoint: Cosmetic Outcome... 4 4. Safety Endpoints... 4 5. Control Group... 5 6. Patient Recruitment and Retention...
More informationMedical Male Circumcision and HSV-2 Acquisition: Post-Trial Surveillance in Kisumu, Kenya
Medical Male Circumcision and HSV-2 Acquisition: Post-Trial Surveillance in Kisumu, Kenya 1 Supriya D. Mehta, MHS, PhD 2,3 Stephen Moses, MD, MPH 4 Kawango Agot, PhD 2 Ian Maclean, PhD 5 Elijah Odoyo-June,
More information11-12 March 2009, Nairobi, Kenya Meeting Report. World Health Organization, Geneva Report prepared by Ariane van der Straten and Tim Farley
Consultation to Review Manufacturing, Clinical and Regulatory Requirements for Male Circumcision Devices to Support Programme Expansion in High HIV Incidence Settings in Africa 11-12 March 2009, Nairobi,
More informationProgress in male circumcision scale-up: country implementation update. December 2009
Progress in male circumcision scale-up: country implementation update December 2009 List of Abbreviations ACHAP AIDS BLM BOTUSA CDC CHAM CIDRZ DHS DMPPT FHI FLAS GFATM HCP HIV HMIS IEC IMC Jhpiego KAP
More informationDr. Syah Mirsya Warli, SpU Dr. Bungaran Sihombing,SpU Div. of Urology, Surgery Dept. Medical Faculty, University of Sumatera Utara
Emergency Room Urology Dr. Syah Mirsya Warli, SpU Dr. Bungaran Sihombing,SpU Div. of Urology, Surgery Dept. Medical Faculty, University of Sumatera Utara Ref : Clinical Manual of Urology, (Philip M. Hanno
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationRavi K. Mootha, M.D. Certified by the American Board of Urology STATEMENTS RELATIVE TO VASECTOMY CONSULTATION
STATEMENTS RELATIVE TO VASECTOMY CONSULTATION The following points relative to performing a segmental vasectomy were discussed in detail and any questions pertaining to the operation or post-operative
More informationTETANUS and VMMC with PrePex RISK ANALYSIS: FINDINGS & RECOMMENDATIONS. For Expert Consultation with WHO March 9 th 2015
TETANUS and VMMC with PrePex RISK ANALYSIS: FINDINGS & RECOMMENDATIONS For Expert Consultation with WHO March 9 th 2015 Experts Risk Analysis - Tetanus and PrePex Page 1 of 48 TABLE OF CONTENTS EXECUTIVE
More informationThe Cryo/Cuff provides two functions: 1. Compression - to keep swelling down. 2. Ice Therapy - to keep swelling down and to help minimize pain. Patients, for the most part, experience less pain and/or
More informationMr. Siva Chandrasekaran Orthopaedic Surgeon MBBS MSpMed MPhil (surg) FRACS
Shoulder Arthroscopy Arthroscopy is a procedure that orthopaedic surgeons use to inspect, diagnose, and repair problems inside a joint. The word arthroscopy comes from two Greek words, "arthro" (joint)
More informationPrimary Endpoint The primary endpoint is overall survival, measured as the time in weeks from randomization to date of death due to any cause.
CASE STUDY Randomized, Double-Blind, Phase III Trial of NES-822 plus AMO-1002 vs. AMO-1002 alone as first-line therapy in patients with advanced pancreatic cancer This is a multicenter, randomized Phase
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationCombination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium
Combination prevention for HIV How to evaluate whether it works? Marie Laga Institute of Tropical Medicine Antwerp, Belgium Preventing HIV includes Create an enabling environment Reduce Exposure behavior
More informationMale circumcision: promise for prevention. Limakatso Lebina Neil Martinson Perinatal HIV Research Unit July 2011
Male circumcision: promise for prevention Limakatso Lebina Neil Martinson Perinatal HIV Research Unit July 2011 WHY ANOTHER C? Circumcision oldest and most common surgery performed. 20-25% of men circumcised.
More informationTorin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015
Estimating the impact of identifying and treating HIV-infected male circumcision clients in Uganda, Zambia, and Swaziland: a mathematical modeling analysis Torin Schaafsma A thesis submitted in partial
More informationTraining of Counsellors for Male Circumcision PARTICIPANT MANUAL. July 2009
Training of Counsellors for Male Circumcision PARTICIPANT MANUAL July 2009 Participant s Name: Service: Acknowledgements This training package (Facilitator and Participant Manuals) was developed in January
More informationAcknowledgements. Abbreviations and Acronyms Definition of Key Terms
CONTENTS Acknowledgements Foreword Abbreviations and Acronyms Definition of Key Terms vii viii ix ix 1. INTRODUCTION 1.1. BACKGROUND 10 1.2. MEDICAL MALE CIRCUMCISION IN SOUTH AFRICA 12 1.3. TARGET AUDIENCE
More informationPrevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)
Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationContraception for Women and Couples with HIV. Knowledge Test
Contraception for Women and Couples with HIV Knowledge Test Instructions: For each question below, check/tick all responses that apply. 1. Which statements accurately describe the impact of HIV/AIDS in
More information( 1 ) Ball and socket. Shoulder capsule. Rotator cuff.
Shoulder Arthroscopy Page ( 1 ) Arthroscopy is a procedure that orthopaedic surgeons use to inspect, diagnose, and repair problems inside a joint. The word arthroscopy comes from two Greek words, arthro
More informationINFORMED CONSENT FOR SLEEVE GASTRECTOMY
INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.
More informationPOINT OF CARE DIAGNOSTICS
ENSURING ACCESS TO POINT OF CARE DIAGNOSTICS IN DECENTRALISED HIV AIDS PROGRAMMES REQUEST FOR EXPRESSION OF INTEREST Technology : Point of Care HIV diagnostic and treatment monitoring devices for Early
More informationThe Anatomy of Success How the Tanzanian Voluntary Medical Male Circumcision (VMMC) Program Became One of the Most Efficient in the Region
The Anatomy of Success How the Tanzanian Voluntary Medical Male Circumcision (VMMC) Program Became One of the Most Efficient in the Region Hally Mahler, MCHIP/Jhpiego/Tanzania Presented at OGAC, 6 July
More informationRepublic of Malawi MALAWI VOLUNTARY MEDICAL MALE CIRCUMCISION COMMUNICATION STRATEGY
Republic of Malawi MALAWI VOLUNTARY MEDICAL MALE CIRCUMCISION COMMUNICATION STRATEGY 2012 2016 MALAWI VOLUNTARY MEDICAL MALE CIRCUMCISION COMMUNICATION STRATEGY 2012 2016 Published By : National AIDS Commission
More informationCardiac Catheterization Lab Procedures
Patient Education Cardiac Catheterization Lab Procedures This booklet describes cardiac catheterization. It also details how to prepare for the procedure and the care needed after it is done. Before You
More informationNew Directions and Shifting Priorities in HIV Prevention (& some Big Picture Questions for Global Health )
HARVARD UNIVERSITY SCHOOL OF PUBLIC HEALTH New Directions and Shifting Priorities in HIV Prevention (& some Big Picture Questions for Global Health ) Daniel Halperin, PhD Department of Global Health and
More informationRisk of HIV infection but not other sexually transmitted diseases is lower among homeless Muslim men in Kolkata
CONCISE COMMUNICATION Risk of HIV infection but not other sexually transmitted diseases is lower among homeless Muslim men in Kolkata Arunansu Talukdar a, Mafafuzur R. Khandokar a, Subir K. Bandopadhyay
More informationQuarterly Research Digest on Voluntary Medical Male Circumcision for HIV Prevention
January 2019 Issue 14 Quarterly Research Digest on Voluntary Medical Male Circumcision for HIV Prevention Combination HIV prevention and HIV testing Costs and costing Enhancing uptake of VMMC Epidemiological
More informationInfluencing Factors of Unsafe Sexual Practices among Dodoma University Students, Tanzania
Journal of Alternative Perspectives in the Social Sciences (2012) Vol 4, No 1, Influencing Factors of Unsafe Sexual Practices among Dodoma University Students, Tanzania L. Madan Mohan, Dodoma University,Tanzania
More informationMinistry of Children and Youth Services. Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW
Chapter 4 Section 4.01 Ministry of Children and Youth Services Autism Services and Supports for Children Follow-up to VFM Section 3.01, 2013 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of
More information